Nova Leap Health Corp. carries a market capitalization of 37.11M, placing it among publicly traded companies globally. Its enterprise value stands at 23.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 37.11M |
| Enterprise Value | 23.19M |
Nova Leap Health Corp. currently has 87.31M shares outstanding.
| Shares Outstanding | 87.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Nova Leap Health Corp. trades at a trailing price-to-earnings ratio of 103.14. The price-to-sales ratio is 0.68, and the price-to-book ratio stands at 1.20.
| PE Ratio | 103.14 |
| PS Ratio | 0.68 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 13.83 |
| P/FCF Ratio | 12.58 |
| P/OCF Ratio | 12.51 |
On an enterprise value basis, Nova Leap Health Corp. trades at an EV/EBITDA multiple of 11.00 and an EV/FCF ratio of 11.95. The EV/Sales ratio of 0.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.54 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.72 |
| EV / EBITDA | 11.00 |
| EV / EBIT | 17.54 |
| EV / FCF | 11.95 |
Nova Leap Health Corp. maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.80, indicating elevated leverage, while an interest coverage ratio of 6.07 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.02 |
| Quick Ratio | 0.94 |
| Debt / Equity | 14.80 |
| Debt / EBITDA | 1.34 |
| Interest Coverage | 6.07 |
Nova Leap Health Corp. posts a return on equity of 1.17 and a return on invested capital of 3.24.
| Return on Equity (ROE) | 1.17 |
| Return on Assets (ROA) | 0.91 |
| Return on Invested Capital (ROIC) | 3.24 |
| Return on Capital Employed (ROCE) | 1.86 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Nova Leap Health Corp. has paid 186,576.00 in income taxes, reflecting an effective tax rate of 46.69.
| Income Tax | 186,576.00 |
| Effective Tax Rate | 46.69 |
Nova Leap Health Corp.'s stock has gained approximately 57.40741% over the past 52 weeks. The 50-day moving average sits at 0.38, while the 200-day moving average is 0.33.
| Beta (5Y) | N/A |
| 52-Week Price Change | 57.40741% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.33 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Nova Leap Health Corp. generated 32.23M in revenue and converted that into 213,022.00 in net income, yielding earnings per share of 0.00. EBITDA reached 2.11M, while operating income came in at 1.32M.
| Revenue | 32.23M |
| Gross Profit | 12.85M |
| Operating Income | 1.32M |
| Pretax Income | 399,598.00 |
| Net Income | 213,022.00 |
| EBITDA | 2.11M |
| EBIT | 1.32M |
| Earnings Per Share (EPS) | 0.00 |
Nova Leap Health Corp. holds 1.61M in cash and equivalents against 2.82M in total debt, resulting in a net debt position of 289,515.00. Total book value stands at 18.37M, with working capital of 79,860.00 providing operational flexibility.
| Cash & Cash Equivalents | 1.61M |
| Total Debt | 2.82M |
| Net Debt | 289,515.00 |
| Equity (Book Value) | 18.37M |
| Book Value Per Share | 0.21 |
| Working Capital | 79,860.00 |
Nova Leap Health Corp. produced 1.76M in operating cash flow over the past twelve months.
| Operating Cash Flow | 1.76M |
| Capital Expenditures | N/A |
| Free Cash Flow | 1.76M |
| FCF Per Share | 0.02 |
Nova Leap Health Corp. operates with a gross margin of 39.87, reflecting its pricing power and cost economics. The operating margin of 4.10 and net profit margin of 0.66 provide insight into operational efficiency.
| Gross Margin | 39.87 |
| Operating Margin | 4.10 |
| Pretax Margin | 1.24 |
| Profit Margin | 0.66 |
| EBITDA Margin | 6.54 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 5.59 |
| FCF Yield | 7.95 |
Nova Leap Health Corp. posts an Altman Z-Score of 9.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.03 |